Resistance to Immune Checkpoint Inhibitor Treatment in Non–Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators
D
Deborah B. Doroshow
T
Ticiana A. Leal
S
Saiama N. Waqar
H
Hossein Borghaei
D
D. Ross Camidge
K
Konstantin H. Dragnev
M
Martin J. Edelman
D
David R. Gandara
D
David E. Gerber
J
Jhanelle E. Gray
(Department of Thoracic Oncology H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA)
F
Fred R. Hirsch
H
Hatim Husain
D
David E. Kozono
N
Natasha B. Leighl
B
Bob T. Li
T
Tianhong Li
P
Philip C. Mack
J
Joel W. Neal
P
Paul K. Paik
S
Sandip P. Patel
J
Jonathan W. Riess
M
Mary W. Redman
K
Karen L. Reckamp
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 1, Issue 1
Published
June 03, 2026
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (23)
D
Deborah B. Doroshow
T
Ticiana A. Leal
S
Saiama N. Waqar
H
Hossein Borghaei
D
D. Ross Camidge
K
Konstantin H. Dragnev
M
Martin J. Edelman
D
David R. Gandara
D
David E. Gerber
J
Jhanelle E. Gray
Department of Thoracic Oncology H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA
F
Fred R. Hirsch
H
Hatim Husain
D
David E. Kozono
N
Natasha B. Leighl
B
Bob T. Li
T
Tianhong Li
P
Philip C. Mack
J
Joel W. Neal
P
Paul K. Paik
S
Sandip P. Patel
J
Jonathan W. Riess
M
Mary W. Redman
K
Karen L. Reckamp
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001